Therefore, overexpression of PD-L1 significantly increases tumor glucose uptake, promotes lymph node metastasis, and is significantly associated with poor prognosis in patients, targeting PD-L1 and its downstream effector molecules as a potential approach to interfere with cervical cancer growth and metastasis. This evidence concerns the gene CD274 and cervical cancer.